-
Featured
New Strategies for Heart Failure Patients Improves Outcomes
One-third of heart failure patients do not respond to cardiac resynchronization therapy (CRT) | A coordinated care approach at Mass General for heart failure patients improves outcomes.
-
Featured
The Promise of Ventricular-Assist Devices (VADs)
VAD technology is continually improving. Mass General data indicates new VADs improve 5-year survival rates. Trials for the latest generation are under way.
-
Biomarkers and Heart Failure
In this video, Hanna Gaggin, MD, MPH, discusses her research in discovering biomarkers of patients with preserved ejection fraction. She hopes that more progress will be made in finding treatment options for patients with type 2 myocardial infarction.
-
Dual-Biomarker Strategy Helps Identify Nonresponders to Cardiac Resynchronization
Measurement of two blood-based biomarkers can identify patients with heart failure that are at risk of nonresponse to cardiac resynchronization therapy and major adverse cardiovascular events afterward.
-
The Links Between Echocardiographically Determined Biventricular Function and Prognosis
Massachusetts General Hospital regularly performs ECMO in adults, and cardiac anesthesiologists here recently investigated the links between echocardiographically determined biventricular function and prognosis.
-
LV Lead Location Affects Long-Term Outcomes of Cardiac Resynchronization Therapy
A post hoc analysis of the MADIT-CRT trial showed that long-term outcomes differ according to left ventricular lead location, as well as by the presence of left bundle branch block at baseline.
Learn more about Mass General's Heart Failure and Cardiac Transplant Program
Heart Failure contributors
-
James Louis Januzzi, MD
Hutter Family Professor of Medicine, Director, Dennis and Marilyn Barry Fellowship in Cardiology Research
Recent Article
Dual-Biomarker Strategy Helps Identify Nonresponders to Cardiac Resynchronization
-
Thoralf M. Sundt, MD
Chief, Division of Cardiac Surgery, Director, Corrigan Minehan Heart Center
Recent Article
Improving the Safety of Vena Caval Thrombectomy in Kidney Cancer with Tumor Thrombus Team Approach
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.Resource links
